Respiratory syncytial virus (RSV) represents a major global healthcare burden, particularly
in those under 5 years of age. There is no available vaccine, with treatment limited to …

Objective To assess the impact of the covid-19 pandemic on hospital admission rates and
mortality outcomes for childhood respiratory infections, severe invasive infections, and …

Importance In early 2020, the United States declared a public health emergency in response
to coronavirus disease 2019 (COVID-19) and implemented a variety of social distancing …

The non-pharmaceutical interventions implemented to slow the spread of SARS-CoV-2 have
had consequences on the transmission of other respiratory viruses, most notably paediatric …

Introduction Interventions to deal with the COVID-19 pandemic may impact the burden of
other respiratory diseases. The aim of this study is to analyze the impact of non …

Seasonal epidemics of influenza and the respiratory syncytial virus (RSV) are the cause of
substantial morbidity and mortality among children. During the global coronavirus disease …

Background Globally, the epidemiology of non‐SARS‐CoV‐2 respiratory viruses like
respiratory syncytial virus (RSV) and influenza virus was remarkably influenced by the …

Objectives To determine the indirect consequences of the COVID-19 pandemic on
paediatric healthcare utilisation and severe disease at a national level following lockdown …

El impacto de la pandemia COVID-19 ha sido invisibilizado en niños, niñas y adolescentes,
ya que muchos de los efectos negativos han sido producto de las medidas de contención y …

Background Children have been less affected by the COVID-19 pandemic, but its
repercussions on pediatric illnesses may have been significant. This study examines the …